SCOPUS 정보 검색 플랫폼

Volumn 85, Issue 12, 2001, Pages 1865-1870

A phase II trial of marimastat in advanced pancreatic cancer

(9) Evans, J D a Stark, A b Johnson, C D c Daniel, F d Carmichael, J e Buckels, J a Imrie, C W b Brown, P f Neoptolemos, J P a,g

a QUEEN ELIZABETH HOSPITAL (United Kingdom)

b GLASGOW ROYAL INFIRMARY (United Kingdom)

c DERRIFORD HOSPITAL (United Kingdom)

d SOUTHAMPTON GENERAL HOSPITAL (United Kingdom)

e NOTTINGHAM CITY HOSPITAL (United Kingdom)

f British Biotech Pharmaceuticals Ltd (United Kingdom)

g ROYAL LIVERPOOL UNIVERSITY HOSPITAL (United Kingdom)

Author keywords

Marimastat; Matrix metalloproteinases; Pancreatic cancer; Toxicity

Indexed keywords

ANALGESIC AGENT; CA 19-9 ANTIGEN; DEXTROPROPOXYPHENE PLUS PARACETAMOL; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANALGESIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BACKACHE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ENZYME INHIBITION; FEMALE; HUMAN; JOINT STIFFNESS; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MULTICENTER STUDY; MYALGIA; NAUSEA; PANCREAS CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0035556141 PISSN: 00070920 EISSN: None Source Type: Journal
DOI: 10.1054/bjoc.2001.2168 Document Type: Article

Times cited : (102)

References (34)

1
- 2142723000
- Chemotherapy for unresectable pancreatic cancer
- Beger H, Warshaw AL, Buchler MW, Carr-Locke DL, Neoptolemos JP, Russell C, Sarr MG (eds). Blackwell Science Oxford
- (1998) The Pancreas , pp. 1120-1138
- Bakkevold, K.E.¹

2
- 0002023426
- Recent advances in matrix metalloproteinase inhibitor research
- (1996) Drug Dev Today , vol.1 , pp. 16-26
- Beckett, R.P.¹ Davison, A.H.² Drummond, A.H.³ Huxley, P.⁴ Whittaker, M.⁵

3
- 0005714980
- 72kDa collagenase, Stromelysin 1 and tissue inhibitor of metalloproteinase 1 expression in pancreatic cancer
- (1994) Digestion , vol.55 , pp. 286
- Bramhall, S.R.¹ Lemoine, N.² Stamp, G.³ Donovan, I.A.⁴ Dunn, J.⁵ Neoptolemos, J.P.⁶

4
- 0028985078
- Incidence, treatment and outcome in 13,600 cases of pancreatic cancer: An epidemiological study in the West Midlands
- (1995) Br J Surg , vol.82 , pp. 111-115
- Bramhall, S.R.¹ Allum, W.H.² Cummings, C.³ Jones, A.G.⁴ Attwood, A.⁵ Neoptolemos, J.P.⁶

5
- 0029979467
- Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of metalloproteinases (TIMP1) in pancreatic and ampullary disease
- (1996) Br J Cancer , vol.73 , pp. 972-978
- Bramhall, S.R.¹ Stamp, G.² Dunn, J.³ Lemoine, N.⁴ Neoptolemos, J.P.⁵

6
- 0030801093
- Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic cancer
- (1997) J Pathol , vol.182 , pp. 347-355
- Bramhall, S.R.¹ Lemoine, N.² Stamp, G.³ Neoptolemos, J.P.⁴

7
- 0035424135
- Marimastat as first line therapy for patients with unresectable pancreatic cancer: A randomized trial
- (2001) J Clin Oncol , vol.19 , pp. 3447-3455
- Bramhall, S.R.¹ Rosemurgy, A.² Brown, P.D.³ Bowry, C.⁴ Buckels, J.A.⁵

8
- 0024503589
- Prolonged activation of jun and collagenase genes by tumour necrosis factor alpha
- (1989) Nature , vol.337 , pp. 661-663
- Brenner, D.A.¹ Ohara, M.² Angel, P.³ Chojkier, M.⁴ Karin, M.⁵

9
- 0027469921
- Association between expression of activated 72-kilodalton gelatinase and tumour spread in non-small cell lung carcinoma
- (1993) J Natl Cancer Inst , vol.85 , pp. 574-578
- Brown, P.D.¹ Bloxidge, R.E.² Stuart, N.S.E.³ Gatter, K.C.⁴ Carmichael, J.⁵

10
- 8244254377
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial
- (1997) J Clin Oncol , vol.15 , pp. 2403-2413
- Burris, H.A.¹ Moore, M.J.² Andersen, J.³ Green, M.⁴ Rothenberg, M.L.⁵ Modiano, M.R.⁶ Cripps, M.C.⁷ Portenoy, R.K.⁸ Torniolo, A.M.⁹ Tarassoff, P.¹⁰ Nelson, R.¹¹ Dorr, F.A.¹² Stephens, C.D.¹³ Von Hoff, D.D.¹⁴

11
- 0026690507
- Evaluation of basement membrane components and the 72kDa type IV collagenase in serous tumours of the ovary
- (1992) Am J Surg Pathol , vol.16 , pp. 500-507
- Campo, E.¹ Merino, M.J.² Tavassoli, F.A.³ Charonis, A.S.⁴ Stetler-Stevenson, W.G.⁵ Liotta, L.A.⁶

12
- 0019880545
- Staging cancer of the pancreas
- (1981) Cancer , vol.47 , pp. 1631-1642

13
- 0002801861
- Mechanism of mineral solublisation and matrix degradation in osteoclastic bone resorption
- Rifkin BR and Gay CV (eds). CRC Press: Boca Raton, Florida
- (1992) Biology and Physiology of the Osteoclast , pp. 290-314
- Delaisse, J.M.¹ Vaes, G.²

14
- 0003099286
- BB-2516: An orally bioavailable matrix metalloproteinase inhibitor with efficacy in animal cancer models
- Abstract
- (1995) Proc Am Assoc Cancer Res , vol.36 , pp. 100
- Drummond, A.¹ Beckett, P.² Bone³

15
- 0019350060
- Randomized study of 5-FU and CCNU in pancreatic cancer: Report of the veterans administration surgical adjuvant cancer chemotherapy study group
- (1980) Cancer , pp. 27-31
- Frey, C.¹ Twomey, P.² Keehn, R.³ Elliot, D.⁴ Higgins, G.⁵

16
- 0029816590
- Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
- (1996) Ann Oncol , vol.7 , pp. 593-600
- Glimelius, B.¹ Hoffman, K.² Sjoden, P.-O.³ Jacobsson, G.⁴ Sellstrom, H.⁵ Enander, L.-K.⁶ Linne, T.⁷ Svensson, C.⁸

17
- 0029806813
- Molecular cloning and characterisation of human tissue inhibitor of metalloproteinase 4
- (1996) J Biol Chem , vol.271 , pp. 30375-30380
- Greene, J.¹ Wang, M.² Liu, Y.E.³ Raymond, L.A.⁴ Rosen, C.⁵ Shi, Y.E.⁶

18
- 0029080314
- Expression and in-situ localisation of gene coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer
- (1995) Int J Cancer , vol.62 , pp. 407-413
- Gress, T.M.¹ Muller-Pillasch, F.² Lerch, M.M.³ Freiss, H.⁴ Buchler, M.⁵ Alder, G.⁶

19
- 0025304539
- Rhematoid arthritis: Pathophysiology and implications for therapy
- (1990) N Engl J Med , vol.322 , pp. 1277-1289
- Harris, E.¹

20
- 0032813495
- The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer
- (1999) Ann N Y Acad Sci , vol.880 , pp. 288-307
- Jones, L.¹ Ghaneh, P.² Humphreys, M.³ Neoptolemos, J.P.⁴

21
- 2142666515
- The expression of matrix metalloprotinases (MMPs 1, 2, 3, 7, 8, 9, 12 and 14) and their inhibitors (TIMP 1, 2 and 3) in pancreatic adenocarcinoma
- (2000) Br J Surg , vol.87 , pp. 676
- Jones, L.E.¹ Campbell, F.² Neoptolemos, J.P.³

22
- 0026425631
- Tumour invasion and metastasis: An imbalance of positive and negative regulation
- (1991) Cancer Res , vol.51 , Issue.SUPPL. , pp. 5054-5059
- Liotta, L.A.¹ Stetler-Stevenson, W.G.²

23
- 0019208060
- Chemotherapy in pancreatic cancer: Results of a controlled prospective randomized multicentre trial
- (1980) Br Med J , vol.281 , pp. 1589-1591
- Mallinson, C.N.¹ Rake, M.D.² Cocking, J.B.³ Fox, C.A.⁴ Cwynarski, M.T.⁵ Diffey, B.L.⁶ Jackson, G.A.⁷ Hanley, J.⁸ Wass, V.J.⁹

24
- 0028928485
- Overexpression of matrix metalloproteinase 7 mRNA in human colon carcinomas
- (1995) Cancer , vol.7 , Issue.5 SUPPL. , pp. 1516-1519
- Mori, M.¹ Barnard, G.F.² Mimori, K.³ Ueo, H.⁴ Akiyoshi, T.⁵ Sugimachi, K.⁶

25
- 0029103339
- Expression of membrane-type matrix metalloproteinase in human gastric carcinomas
- (1995) Cancer Res , vol.55 , pp. 3263-3266
- Nomura, H.¹ Sato, H.² Seiki, M.³ Mai, M.⁴ Okada, Y.⁵

26
- 0345843723
- NYCRIS: Leeds, UK. (In press)
- (2000) Cancer treatment policies and their effects on survival: Pancreas

27
- 0026013537
- Expression of metalloproteinase genes in human prostate cancer
- (1991) J Cancer Res Clin Oncol , vol.117 , pp. 144-150
- Pajouh, M.S.¹ Nagle, R.B.² Breatynach, R.³ Finch, J.S.⁴ Brawler, M.K.⁵ Bowden, G.T.⁶

28
- 0028291349
- Chemotherapy prolongs survival in inoperable pancreatic carcinoma
- (1994) Br J Surg , vol.81 , pp. 882-885
- Palmer, K.R.¹ Kerr, M.² Knowles, G.³ Cull, A.⁴ Carter, D.C.⁵ Leonard, R.C.F.⁶

29
- 0028952765
- Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin 3 and NM-40/SPARC genes
- (1995) Int J Cancer , vol.64 , pp. 70-75
- Porte, H.¹ Chastre, E.² Prevot, S.³ Nordlinger, B.⁴ Empereur, S.⁵ Basset, P.⁶ Chambon, P.⁷ Gespach, C.⁸

30
- 0018360377
- Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases
- (1997) Biochem Biophys Res Commun , vol.87 , pp. 581-587
- Sellers, A.¹ Murphy, G.² Meickle, M.C.³ Reynolds, J.J.⁴

31
- 0018972967
- 5-Fluorouracil, adriamycin and mitimycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas
- (1980) Cancer , vol.46 , pp. 2014-2018
- Smith, P.F.¹ Hoth, D.F.² Levin, B.³ Karlin, D.A.⁴ MacDonald, J.S.⁵ Wooley, P.V.⁶

32
- 0024394212
- Tissue inhibitor of metalloproteinase (TIMP 2)
- (1989) J Biol Chem , vol.264 , pp. 17374-17378
- Stetler-Stevenson, W.G.¹

33
- 0028355246
- Structure and expression in breast tumours of human TIMP 3, a new member of the metalloproteinase inhibitor family
- (1994) Cancer Res , vol.54 , pp. 2091-2094
- Uria, J.A.¹ Ferrando, A.A.² Velasco, G.³ Freije, J.M.P.⁴ Lopez-Otin, C.⁵

34
- 0026621123
- Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing
- (1992) J Invest Dermatol , vol.99 , pp. 870-872
- Wolf, C.¹ Chenard, M.P.² Durand de Grossouvre, P.³ Bellocq, J.P.⁴ Chambon, P.⁵ Basset, P.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.